PALLAS: Insights into permanent atrial fibrillation
In recent months, pharmaco-vigilance alerts have emerged for dronedarone, followed by discontinuation of the Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy (PALLAS) study in July…